Peer-influenced content. Sources you trust. No registration required. This is HCN.
EP – Europace
In this 22-center study of repeat ablations following PFA, 45% of patients maintained complete pulmonary vein isolation from their initial procedure, with subsequent success rates varying significantly by arrhythmia type.
Cardiology February 10th 2025
Journal of the American College of Cardiology (JACC)
In this comprehensive analysis of 2,853 TTS patients, beta-blocker therapy demonstrated a significant 29% reduction in mortality risk during follow-up, particularly within the first year after discharge.
Psych Congress Network
Analysis of more than 16.6 million pregnancies shows no significant increase in adverse outcomes for women maintaining methylphenidate or atomoxetine treatment during pregnancy.
Neurology January 22nd 2025
Journal of the National Cancer Institute (JNCI)
In a cohort of 601 women aged ≥65 years with low-risk breast cancer treated without radiotherapy, the 10-year local recurrence rate was 5.5%, with only 0.5% breast cancer-specific mortality.
Geriatrics January 21st 2025
Consultant360
Lichen nitidus presents a diagnostic challenge that requires careful differentiation from other penile lesions, with management approaches ranging from watchful waiting to active intervention based on presentation severity.
Dermatology December 12th 2024
Oncology News Central (ONC)
Durvalumab consolidation therapy demonstrated unprecedented survival benefit in limited-stage SCLC, extending median overall survival by nearly two years compared to placebo.
Oncology, Medical December 3rd 2024